Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab for periprosthetic osteolysis after uncemented total hip arthroplasty
2013-004940-48Phase 2Completed
- Sponsor
- Danderyds sjukhus
- Start
- Oct 2014
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Aseptic loosening (AL) comparing Denosumab with Placebo (2 arms). Started Oct 2014; status: completed.
02
Drugs
denosumab
03
Conditions
Aseptic loosening (AL)
Beyond the preview
Go deeper on 2013-004940-48.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004940-48.